Opthea Limited (AU:OPT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Opthea Limited announced a change in the interest of its director, Dr. Susan Orr, with the granting of 2 million unquoted options under the NED Plan. These options allow the acquisition of fully paid ordinary shares at a reduced exercise price, with an expiration date extending into 2034. This development is likely to draw investor attention considering the potential for long-term returns.
For further insights into AU:OPT stock, check out TipRanks’ Stock Analysis page.
